Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.870
+0.111 (14.62%)
At close: Nov 22, 2024, 4:00 PM
1.090
+0.220 (25.29%)
After-hours: Nov 22, 2024, 7:59 PM EST

Biofrontera Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
35.3634.0728.6724.118.8526.18
Revenue Growth (YoY)
5.17%18.82%18.98%27.86%-28.01%-
Cost of Revenue
18.717.4415.1912.749.0712.41
Gross Profit
16.6616.6313.4911.369.7813.77
Selling, General & Admin
33.4537.93525.9618.1228.4
Research & Development
1.340.08----
Operating Expenses
34.7937.983525.9618.1228.4
Operating Income
-18.14-21.35-21.51-14.6-8.33-14.62
Interest Expense
-2.34-0.6-0.37-0.36-2.9-2.16
Interest & Investment Income
0.130.130.180.020.030.03
Currency Exchange Gain (Loss)
-0.11-0.11-0.03---
Other Non Operating Income (Expenses)
2.463.0416.36-12.650.080.18
EBT Excluding Unusual Items
-18-18.89-5.38-27.6-11.12-16.58
Merger & Restructuring Charges
----0.75-1.13-3.53
Gain (Loss) on Sale of Investments
-0.8-7.421.75---
Gain (Loss) on Sale of Assets
------0.59
Legal Settlements
6.166.16-0.87-11.25--
Other Unusual Items
-0.180.033.891.941.339.75
Pretax Income
-12.82-20.12-0.61-37.66-10.92-10.95
Income Tax Expense
0.020.010.030.060.060.03
Net Income
-12.84-20.13-0.64-37.71-10.99-10.98
Net Income to Common
-12.84-20.13-0.64-37.71-10.99-10.98
Shares Outstanding (Basic)
4210--
Shares Outstanding (Diluted)
4210--
Shares Change (YoY)
209.37%46.29%140.00%---
EPS (Basic)
-3.08-13.02-0.61-85.63--
EPS (Diluted)
-3.09-13.02-0.61-85.63--
Free Cash Flow
--24.9-16.24-26.73-12.37-38.22
Free Cash Flow Per Share
--16.10-15.36-60.68--
Gross Margin
47.10%48.80%47.04%47.13%51.90%52.61%
Operating Margin
-51.30%-62.67%-75.02%-60.59%-44.21%-55.85%
Profit Margin
-36.31%-59.09%-2.23%-156.49%-58.29%-41.95%
Free Cash Flow Margin
--73.08%-56.63%-110.90%-65.62%-145.96%
EBITDA
-17.62-20.85-20.99-14.06-7.77-13.96
EBITDA Margin
-49.84%-61.19%-73.21%-58.34%-41.23%-53.30%
D&A For EBITDA
0.520.50.520.540.560.67
EBIT
-18.14-21.35-21.51-14.6-8.33-14.62
EBIT Margin
-51.30%-62.67%-75.02%-60.59%-44.21%-55.85%
Revenue as Reported
35.3634.0728.6724.118.8526.18
Advertising Expenses
-0.20.10.5--
Source: S&P Capital IQ. Standard template. Financial Sources.